Aratana Therapeutics Inc. (Nasdaq: PETX) must provide additional information to the Center for Veterinary Medicine for its appetite stimulation medication Entice sending the stock price tumbling $1.44 to close at $6.59.
Aratana Therapeutics must provide additional information
February 06, 2017 at 17:52 PM EST
